US FDA Approves Vertex's Non-Opioid Painkiller
(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...
FDA Approves New Painkiller That Shows Promise and Challenges of Opioid Alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Hosted on MSN9h
Red Dye No. 3 Can Be Found in These 9 Foods in Your Pantry
The US Food and Drug Administration has revoked its authorization of Red No. 3 in food, drinks and ingested drugs across the ...
Sierra Sun Times13h
California Congressman Josh Harder Introduces Bipartisan Bill to Cut Costly Red Tape in Pet Food Industry for Better Nutrition and Quality
California Congressman Josh Harder Introduces Bipartisan Bill to Cut Costly Red Tape in Pet Food Industry for Better Nutrition and Quality ...
MLive2h
This chocolate recall has been upgraded to FDA’s highest risk level
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
Eagle-Tribune4h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Halted research, disciplined doctors: internal audit finds Kaiser ignored patient protections in California study
Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...
Takeaways from RFK Jr.’s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two ...
R Street Institute6hOpinion
Trump: Look at the Slow-Moving FDA
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
Uncertainty, chaos for Canadian researchers as confusion reigns over Trump administration medical funding
Canadian scientists say the uncertainty surrounding U.S. President Donald Trump's pause on federal health spending there ...